SLS

BreakingConviction 91LongHealthcareScan · Thu, Jun 25, 2026

High tight flagmomentum

SLS$10.54+14.94%

ResistanceSupportVol 14

Vol MA14 7.94M

Mar 26Apr 14May 1May 19Jun 8Jun 25

WSB mentions · 24h changelatest +52.94%· 52 mentions

Mar 26Apr 14May 1May 19Jun 8Jun 25

Trade plan

LongReward : Risk0.20

Entry

10.54

Risk

Stop

7.71

-26.8% to stop

Reward

Target 1

11.11

+5.4% to target

Stretch

Target 2

11.68

+10.8% to T2

Risk : reward balance

Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

SELLAS Life Sciences Group, Inc.PHARMACEUTICAL PREPARATIONSwww.sellaslifesciences.com ↗

Price10.54

Change+14.94%

Gap+1.96%

Rel volume3.03×

Avg volume9.05M

Avg $ vol79.19M

SMA 208.41

SMA 506.88

SMA 2004.05

Price vs 50+53.30%

Price vs 200+160.28%

MA stackbullish

50/200 cross—

Supertrendup · 7.53

RSI (14)72

MACD hist0.13

MACD crossbull · 1d

Stoch %K / %D87 / 91

ADX (14)31

+DI / −DI40 / 11

RSI divergence—

MACD divergence—

ATR %+7.49%

ADR %8.61%

52w high10.54

52w low1.39

From 52w high+0.00%

Above 52w low+658.27%

New 52w highYes

SqueezeOff

Bollinger width38.00%

%B1.17

Donchian pos87.19%

Donchian high11.05

Donchian low7.07

AVWAP (52w high)10.19

vs AVWAP high+3.43%

AVWAP (52w low)5.15

vs AVWAP low+104.51%

OBV trendUp

Chaikin MF (20)0.10

Today vs 20d3.03×

Avg vol (14d)7.94M

Avg vol (20d)9.05M

Avg $ vol (20d)79.19M

Market cap1.96B

RS 3m (vs SPY)+71.33%

RS 6m (vs SPY)+280.82%

RS line new highYes

Trend template8/8

Technical rank97.5

1 week+35.82%

1 month+29.80%

3 months+98.87%

6 months+299.24%

1 year+495.48%

YTD+142.30%

P/E-72.99

P/B18.25

P/S—

P/FCF-69.05

EPS-0.2500

Div yield—

ROE-25.01%

ROA-23.53%

Debt/Eq0.00

Current17.22

EV/EBITDA-65.89

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth13.01%

Price target10.00

Target upside-5.12%

Analyst ratingBuy

Institutional33.55%

Ent. value1.85B

Revenue0

Net income-8.41M

Gross profit869K

Free cash flow-28.39M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out196.63M

Employees13

ListedWed, Mar 12, 2008

Free float182.12M

Float %98.7%

Short interest61M

Days to cover4.4d

Short volume52.7%

Squeeze score86 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.05

Last surprise—

Setup gradeA+

Conviction91 / 100

Pattern quality65%

Tech rank97.5 / 100

Group rank50 / 100

Status laneBreaking out now

Setup directionLong

Pattern familyMomentum

Resistance9.51

Support7.91

Days since event0d

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 16 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jun 4
1 scan
→
Breaking out now
Jun 25
1 scan

Congress activity

Disclosed STOCK Act trades in SLS

All disclosures →

No recent disclosed trades by Congress in SLS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SLS · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Stergiou Angelos M. President and CEO · Common Stock · 2026-06-16	Grant	1.06M	—	2026-06-16	2026-06-18

SEC filings

EDGAR filings in SLS · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.